293 related articles for article (PubMed ID: 22736596)
1. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs.
Fonsato V; Collino F; Herrera MB; Cavallari C; Deregibus MC; Cisterna B; Bruno S; Romagnoli R; Salizzoni M; Tetta C; Camussi G
Stem Cells; 2012 Sep; 30(9):1985-98. PubMed ID: 22736596
[TBL] [Abstract][Full Text] [Related]
2. Role of Lefty in the anti tumor activity of human adult liver stem cells.
Cavallari C; Fonsato V; Herrera MB; Bruno S; Tetta C; Camussi G
Oncogene; 2013 Feb; 32(7):819-26. PubMed ID: 22469982
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles from human liver stem cells inhibit tumor angiogenesis.
Lopatina T; Grange C; Fonsato V; Tapparo M; Brossa A; Fallo S; Pitino A; Herrera-Sanchez MB; Kholia S; Camussi G; Bussolati B
Int J Cancer; 2019 Jan; 144(2):322-333. PubMed ID: 30110127
[TBL] [Abstract][Full Text] [Related]
4. Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib.
He C; Jaffar Ali D; Xu H; Kumaravel S; Si K; Li Y; Sun B; Ma J; Xiao Z
Exp Cell Res; 2020 Jul; 392(2):112040. PubMed ID: 32380039
[TBL] [Abstract][Full Text] [Related]
5. Adipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31.
Kang T; Jones TM; Naddell C; Bacanamwo M; Calvert JW; Thompson WE; Bond VC; Chen YE; Liu D
Stem Cells Transl Med; 2016 Apr; 5(4):440-50. PubMed ID: 26933040
[TBL] [Abstract][Full Text] [Related]
6. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats.
Herrera MB; Fonsato V; Gatti S; Deregibus MC; Sordi A; Cantarella D; Calogero R; Bussolati B; Tetta C; Camussi G
J Cell Mol Med; 2010 Jun; 14(6B):1605-18. PubMed ID: 19650833
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo.
Brossa A; Fonsato V; Grange C; Tritta S; Tapparo M; Calvetti R; Cedrino M; Fallo S; Gontero P; Camussi G; Bussolati B
Int J Cancer; 2020 Sep; 147(6):1694-1706. PubMed ID: 32064610
[TBL] [Abstract][Full Text] [Related]
8. Microvesicle microRNA profiles and functional roles between chronic hepatitis B and hepatocellular carcinoma.
Li H; Sun L; Chen X; Xiong W; Hu D; Jie S
Clin Transl Oncol; 2014 Mar; 16(3):315-21. PubMed ID: 23864279
[TBL] [Abstract][Full Text] [Related]
9. Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth.
Bruno S; Collino F; Deregibus MC; Grange C; Tetta C; Camussi G
Stem Cells Dev; 2013 Mar; 22(5):758-71. PubMed ID: 23034046
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiles of circulating microvesicles in hepatocellular carcinoma.
Sun L; Hu J; Xiong W; Chen X; Li H; Jie S
Acta Gastroenterol Belg; 2013 Dec; 76(4):386-92. PubMed ID: 24592541
[TBL] [Abstract][Full Text] [Related]
12. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs.
Collino F; Deregibus MC; Bruno S; Sterpone L; Aghemo G; Viltono L; Tetta C; Camussi G
PLoS One; 2010 Jul; 5(7):e11803. PubMed ID: 20668554
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
[TBL] [Abstract][Full Text] [Related]
14. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
15. Human Liver Stem Cell Derived Extracellular Vesicles Alleviate Kidney Fibrosis by Interfering with the β-Catenin Pathway through miR29b.
Kholia S; Herrera Sanchez MB; Deregibus MC; Sassoè-Pognetto M; Camussi G; Brizzi MF
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639119
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2.
Xu X; Zou H; Luo L; Wang X; Wang G
FEBS Open Bio; 2019 Oct; 9(10):1784-1797. PubMed ID: 31408273
[TBL] [Abstract][Full Text] [Related]
17. Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels.
Su Y; Cheng R; Zhang J; Qian J; Diao C; Ran J; Zhang H; Li L
Life Sci; 2015 Dec; 143():18-26. PubMed ID: 26518164
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.
Yuan X; Zhang Q; Li Z; Zhang X; Bao S; Fan D; Ru Y; Dong S; Zhang Y; Zhang Y; Ye Z; Xiong D
Cancer Lett; 2016 Oct; 381(1):85-95. PubMed ID: 27450327
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-γ and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.
Wang H; Wang J; Shi X; Ding Y
J BUON; 2017; 22(6):1517-1524. PubMed ID: 29332347
[TBL] [Abstract][Full Text] [Related]
20. Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity.
Zhao QQ; Hu YL; Zhou Y; Li N; Han M; Tang GP; Qiu F; Tabata Y; Gao JQ
Int J Nanomedicine; 2012; 7():3191-202. PubMed ID: 22811604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
